Fidelity International’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Fidelity International’s Portfolio SURF Stock Details SURF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-647,317	Closed	-$1.21M	–	940
2020 Q1	$1.21M	Hold	647,317	–	–	﹤0.01%	596
2019 Q4	$1.22M	Hold	647,317	–	–	﹤0.01%	636
2019 Q3	$919K	Hold	647,317	–	–	﹤0.01%	630
2019 Q2	$1.82M	Buy	647,317 +6,104	+1%	+$24.3K	﹤0.01%	607
2019 Q1	$3.06M	Sell	641,213 -328,880	-34%	-$1.62M	﹤0.01%	548
2018 Q4	$4.11M	Buy	970,093 +83,377	+9%	+$644K	0.01%	528
2018 Q3	$9.7M	Hold	886,716	–	–	0.01%	487
2018 Q2	$14.5M	Buy	+886,716	New	+$12.8M	0.02%	442

Other funds holding SURF

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

AVAI

Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

GTC

Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity International's SURF Position: Q2 2020 in Review

Fidelity International sold out of Surface Oncology, Inc. Common Stock (SURF) in Q2 2020, closing a stake of 647,317 shares — an estimated $1.21M sold.

Fidelity International first reported a position in SURF in Q2 2018 and held it in 8 quarters. The position peaked at $14.5M in Q2 2018. 44 funds tracked by Wall St. Rank hold SURF as of Q2 2020.

Fidelity International reported no remaining Surface Oncology, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Fidelity International sold 647,317 Surface Oncology, Inc. Common Stock shares in Q2 2020, an estimated $1.21M.
Fidelity International first reported a position in Surface Oncology, Inc. Common Stock in Q2 2018 and held it in 8 quarters.
Fidelity International's Surface Oncology, Inc. Common Stock position peaked at $14.5M in Q2 2018.
44 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q2 2020.

Based on Fidelity International's 13F filing for Q2 2020, filed 13 Aug 2020.